Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

This year has seen a double dose of optimism in the field of HIV prevention. First ... 2025 and by shifting “at least two million clients on firstline antiretroviral treatments to use African-made ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...

The 2024 Sex Lives Report by LetsStopAIDS found 34% of youth diagnosed with an STI or HIV did not receive treatment — an ...

A cancer expert, Professor Adeniyi Adenipekun, said the current efforts to subside cancer drugs for accessibility to patients ...